NY Goes After MedImmune In Kickback Scheme Suit
The AstraZeneca subsidiary MedImmune ripped off the government by teaming up with a specialty pharmacy to aggressively pursue sensitive patient information and increase sales of the infant lung drug Synagis, the...To view the full article, register now.
Already a subscriber? Click here to view full article